Gore has expertise in medical device development and drug delivery technologies and their investment complements our recently announced collaborative research agreement aimed at improving the performance of the PEC - Encap product candidate,» said Paul Laikind, Ph.D., president and chief executive officer of ViaCyte. (viacyte.com)
«In addition to our recently announced collaborative research agreement with ViaCyte, Gore's investment should strengthen our collaboration with ViaCyte and accelerate the development of the PEC - Encap product candidate,» said Edward Gunzel, Technical Leader for Gore PharmBIO Products. (viacyte.com)
SAN FRANCISCO, CA — The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A / S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases. (gladstone.org)